At a glance
The Wisconsin pharmacy decision starts with about $803,000 of cash
For a founder-scale independent community pharmacy, the statewide planning case is capital-heavy even though Wisconsin's core state filing fees are modest. The Typical scope requires about $803,000 before opening; Lean is about $471,000 and Premium about $1.26 million. Those totals are 2026 planning dollars for one 2,000-square-foot leased store and include opening inventory, liquidity and an operating-cash reserve rather than treating those balances as expenses.
The configuration is fixed so Wisconsin – not a format change – drives the state overlay. Wisconsin licensing requires an in-state pharmacy credential, a managing pharmacist and a pre-opening self-inspection; the application instructions say the completed application, fee and materials must be filed at least 30 days before the proposed opening and the pharmacy may not operate until the credential is granted. See the Wisconsin DSPS pharmacy application instructions.
The legal/tax convention is a domestic single-member LLC that remains disregarded for income tax while operating as an employer. This is a modeling choice, not entity-selection advice; see the Department of Revenue guidance.
Startup scope
Drug inventory – not the license fee – drives Wisconsin opening cash
The project-cost range is built line by line. Known core filings in the Typical case are about $1,158 before local/administrative allowances: $130 online LLC formation, $60 pharmacy application, $20 Business Tax Registration, $888 three-year DEA registration and $60 for two technician credentials. Sources are the Department of Financial Institutions, Department of Revenue and DEA.
| Use of funds | Lean | Typical | Premium |
|---|---|---|---|
| Site, fit-out and systems | |||
| Refundable lease/security deposit | $10,000 | $15,000 | $22,000 |
| Build-out and secure pharmacy area | $70,000 | $150,000 | $260,000 |
| Fixtures, refrigeration, safe, alarm and equipment | $55,000 | $95,000 | $155,000 |
| Pharmacy system hardware and POS setup | $15,000 | $28,000 | $45,000 |
| Site/systems subtotal | $150,000 | $288,000 | $482,000 |
| Pre-opening expense and launch | |||
| Regulatory filings and local permit allowance | $2,000 | $2,000 | $2,000 |
| Legal, accounting, design and payer setup | $15,000 | $30,000 | $50,000 |
| Insurance deposits | $8,000 | $12,000 | $18,000 |
| Pre-opening payroll and training | $12,000 | $25,000 | $40,000 |
| Launch marketing and signage | $8,000 | $15,000 | $25,000 |
| Utility and subscription deposits | $4,000 | $6,000 | $9,000 |
| Pre-opening subtotal | $49,000 | $90,000 | $144,000 |
| Inventory and liquidity | |||
| Opening prescription inventory | $140,000 | $215,000 | $300,000 |
| Opening OTC and clinical supplies | $12,000 | $20,000 | $35,000 |
| Initial net working capital, excluding inventory | $15,000 | $25,000 | $40,000 |
| Opening operating-cash reserve | $80,000 | $115,000 | $175,000 |
| Contingency | $25,000 | $50,000 | $80,000 |
| Inventory/liquidity subtotal | $272,000 | $425,000 | $630,000 |
| Total project cost | $471,000 | $803,000 | $1,256,000 |
Startup scope comparison – Wisconsin statewide model, 2026 USD
The Typical $215,000 prescription-inventory allowance is a derived planning estimate, not a Wisconsin wholesaler quote. An older NCPA startup study reported prescription inventory turning roughly every 30 days; applying that operating rhythm to the current modeled drug-cost base yields a similar order of magnitude. The study also warned that startups commonly underestimate working capital. Use the NCPA startup benchmark as directional evidence only, then replace the allowance with actual wholesaler opening-order and payment terms.
Licensing and launch
The pharmacy license and payer setup can overlap, but opening cannot
The critical path is not a simple sum of filing times. Entity, tax, site and build-out work can run in parallel with payer and vendor setup, but a retail pharmacy must still reach the state credential and local occupancy gates before operating. The model uses a 16 – 24 week total launch window; that is a planning range, not a Wisconsin agency service-level promise.
| Requirement | Authority | Initial fee | Timing/status | Dependency | Official source |
|---|---|---|---|---|---|
| Domestic LLC | Wisconsin DFI | $130 online; +$100 optional expedite | Before contracts/tax accounts | $25 annual report thereafter | DFI |
| EIN | IRS | $0 | Early launch step | Needed for many banking/payroll/vendor workflows | IRS |
| Business Tax Registration / seller-employer accounts | Wisconsin DOR | $20 BTR; $10 renewal | Before taxable sales/employment | Set POS taxability by product/service | DOR |
| In-state pharmacy credential | Wisconsin DSPS / Pharmacy Examining Board | $60 application | File complete package ≥30 days before proposed opening | Floor plan, self-inspection, managing pharmacist; no operation before grant | DSPS |
| Managing pharmacist / pharmacist credential | Wisconsin DSPS | Owner already licensed in this model | Must be in place for application/operation | Pharmacy renewal $74; pharmacist renewal $74 on published schedule | DSPS fees |
| Pharmacy technician credentials | Wisconsin DSPS | $30 each | Before technician practice | Two registrations modeled at launch | DSPS tech |
| DEA retail-pharmacy registration | U.S. DEA | $888 / 3 years; confirm at filing | After required state authority | Controlled-substance dispensing | DEA |
| NPI, NCPDP and payer enrollment | CMS / industry / payers | NPI $0; NCPDP/payer costs vary | 8 – 16 weeks modeled as a workstream | Required to route many reimbursed claims; payer SLA not universal | CMS |
| Workers' compensation / unemployment insurance | Wisconsin DWD | Premium/rate depends on payroll and carrier | Employer rules apply as thresholds are met | Canonical staffing clearly triggers workers' compensation coverage | DWD |
| Zoning, occupancy, building, fire and signage approvals | City/county and other local authorities | Varies by city/county | Confirm before unconditional lease/build-out | Scope depends on final address and work | Local quote / issuing authority required |
DSPS lists a permanent pharmacy workplace-conditions rule effective June 1, 2026. Staffing, tools and time to perform pharmacy services safely are therefore compliance inputs as well as cost inputs. Confirm current text on the DSPS rulemaking page and Pharmacy Examining Board rules page.
Operating economics
At 135 prescriptions a day, the Base case reaches $3.36 million
The revenue model uses earned operating revenue rather than cash receipts. Prescription revenue is the net amount earned after contractual reimbursement and customer responsibility; sales/use tax collected is excluded. Front-end sales are modeled separately, and clinical/admin revenue is kept distinct because taxability and payer treatment can differ. Payment and network fees are shown as variable costs rather than netted from revenue.
| Metric | Downside | Base | Upside |
|---|---|---|---|
| Prescriptions/day | 95 | 135 | 165 |
| Annual prescriptions | 29,640 | 42,120 | 51,480 |
| Average earned revenue / Rx | $72 | $74 | $75 |
| Monthly total revenue | $191,840 | $279,740 | $346,750 |
| Annual total revenue | $2,302,080 | $3,356,880 | $4,161,000 |
| Contribution margin | 17.73% | 20.24% | 20.80% |
| Passive cash operating profit / month | – $5,360 | $17,232 | $29,780 |
| Working-owner cash benefit / month | $8,771 | $31,362 | $43,910 |
| Working-owner payback | 121 mo | 33 mo | 25 mo |
Monthly revenue by scenario – Wisconsin statewide model, Typical scope, 2026 USD
The prescription margin anchor is deliberately conservative. NCPA's 2025 Digest summary reports that independent community pharmacies averaged a 18.2% gross profit margin in 2024, 67,601 prescriptions per location annually and about 217 prescriptions per day. The Base case applies an 18.2% prescription gross margin before the separate front-end and clinical mix; at 42,120 annual prescriptions, it remains below the mature independent volume benchmark. See the NCPA 2025 Digest summary.
Prescription dispensing
92.9%of Base revenue. The model uses $74 earned revenue per filled prescription and 81.8% drug COGS. Actual economics must be rebuilt from wholesaler files and payer remittances.
OTC / front end
5.0%$14,000 per month with 62% merchandise COGS. This is a modeled secondary stream, not a reason to underwrite the store like a general retailer.
Clinical / admin
2.1%$6,000 per month with 12% direct supplies. The basket includes immunization/adherence and related services but excludes compounding and specialty pharmacy.
Tax map: Wisconsin exempts qualifying prescription drugs for humans, including covered patient copayments, while many OTC/front-end items remain taxable. Service treatment can depend on what is sold and how a bundle is structured, so the POS should map taxability by SKU/service rather than apply one blended rate. The model excludes collected sales tax from revenue. Review the Department of Revenue prescription-drug guidance and the current tax-rate guidance for the final address.
Cost structure
Wisconsin pharmacist wages change the owner-versus-passive result
A pharmacy can look profitable only because the pharmacist-owner is working without a market-value labor charge. This model separates labor compensation from the residual return on capital. The Base owner-replacement salary uses Wisconsin pharmacist median pay of about $148,740 annually from May 2025, then adds a modeled 14% employer burden, producing about $169,564 per year, or $14,130 per month.
The non-owner Base payroll includes two pharmacy-technician FTEs at a Wisconsin median of about $45,970 each, loaded by 12%; 0.2 FTE of relief pharmacist coverage; and 0.5 FTE of front-counter/clerical coverage at a modeled $19/hour. This produces about $13,251 per month of non-owner payroll. BLS's May 2025 state occupational wage release is the wage basis; benefit loads and the clerical rate are explicit planning assumptions, not BLS figures.
| Bridge item | Monthly amount |
|---|---|
| Net operating revenue | $279,740 |
| Variable COGS, supplies and processing/network fees | – $223,126 |
| Passive-basis contribution | $56,614 |
| Non-owner payroll | – $13,251 |
| Occupancy, 2,000 sq. ft. | – $3,400 |
| Other fixed cash overhead | – $8,600 |
| Fixed pharmacist-owner replacement labor, fully loaded | – $14,130 |
| Normalized passive-owner cash operating profit before D&A | $17,232 |
| Replacement labor avoided by working owner | +$14,130 |
| Working-owner pre-tax business cash benefit | $31,362 |
| Maintenance-capex reserve | – $1,500 |
| Potential working-owner cash before personal income tax | $29,862 |
The $8,600 “other fixed cash overhead” comprises $850 utilities, $1,500 insurance, $1,500 pharmacy software/POS/claims/DSCSA systems, $1,200 marketing, $850 professional services, $650 security/cleaning/waste, $250 licensing/admin/dues, $600 maintenance, $300 communications and $900 miscellaneous shrink/small tools. Insurance and technology require quotes; the rest are modeled allowances.
No depreciation-and-amortization schedule is fabricated, so the article does not label $17,232 as EBIT. It is normalized cash operating profit before D&A. Debt is also excluded from the Base project: debt principal, interest, personal income tax and owner distributions do not belong inside operating expenses. If financing is later committed, model amount financed, fees, APR, amortization and scheduled principal/interest below operating profit.
Unit economics
Break-even is reachable; margin is the harder test
The natural production unit is a filled prescription, but the store also earns attached OTC and clinical revenue. The Base calculation therefore uses a prescription-equivalent: one filled prescription plus its proportional share of the stated front-end and clinical streams. This is a modeling unit, not a claim that each patient transaction is priced identically.
| Metric | Base result | Formula / basis |
|---|---|---|
| Revenue per prescription-equivalent | $79.70 | $3,356,880 ÷ 42,120 Rx |
| Variable cost per prescription-equivalent | $63.57 | Drug/merchandise COGS + clinical supplies + 0.45% processing/network fees |
| Passive/economic contribution per unit | $16.13 | $79.70 – $63.57; no variable owner labor in this capacity band |
| Contribution margin | 20.24% | $16.13 ÷ $79.70 |
| Cash-survival break-even | $124,772/mo | $25,251 fixed non-owner cash cost ÷ 20.24% |
| Cash-survival volume | 60 Rx-eq/day | 35.4% of 170/day capacity |
| Sustainable working-owner break-even | $186,018/mo | Fixed cash cost + $12,395/month target owner compensation ÷ 20.24% |
| Passive-owner break-even | $194,593/mo | Fixed cash cost + $14,130 loaded replacement labor ÷ 20.24% |
| Passive-owner volume | 94 Rx-eq/day | 55.2% of 170/day capacity |
Break-even capacity use – Wisconsin statewide Base mix, Typical scope, 2026
The owner's pharmacist-manager role is treated as fixed or step-fixed within the 0 – 170 prescription/day band, so no owner-replacement labor is deducted in unit contribution. That avoids counting the same $14,130 twice: it sits in the passive-owner fixed-cost numerator. If the owner instead personally performs a clearly volume-variable service block, the variable share of replacement labor must move into unit contribution and out of fixed break-even costs.
Runway and return
The Base cash schedule repays founder equity in month 33
Payback is calculated from a monthly cumulative founder-equity schedule, not by dividing startup cost by one stabilized annual profit number. Month 0 begins at negative $803,000. The opening operating reserve is already funded there, so early ramp losses paid from that reserve are not counted a second time as new capital.
Downside
121 monthsWorking-owner, pre-tax. The $115,000 opening reserve cannot preserve the $100,000 floor through the weak ramp without about $32,000 of later owner top-ups.
Base
33 monthsWorking-owner, pre-tax, no debt. Reserve trough is about $101,000 in month 2 and rebuilds to the $115,000 target by month 5.
Upside
25 monthsWorking-owner, pre-tax. Capacity is nearly full at 165 prescriptions/day, so this is not a license to extrapolate growth indefinitely.
The Base ramp assumes 30%, 40%, 50%, 60%, 70%, 80%, 85%, 90%, 95% and then 100% of stabilized contribution over months 1 – 10, while fixed cash costs are incurred from opening. Maintenance-capex reserve is $1,500 per month. No personal income-tax reserve is modeled; no owner distribution is released until the operating-cash reserve has recovered to its $115,000 target. Additional net working capital is not assumed after stabilization, so a real founder should rerun the schedule when payer receivables or wholesaler terms differ.
Debt can reduce the closing equity check, not project cost. A financed case must include only committed proceeds available when uses are payable and then deduct scheduled principal and interest. Founder-equity payback uses post-debt cash to equity; unlevered project payback uses cash to all capital providers.
Address diligence
One address should not stand in for Wisconsin
The statewide Base case uses state rules where they exist and a disclosed multi-market basket where they do not. Local land-use, building, occupancy, fire and signage requirements are not averaged into a fictional Wisconsin permit. They remain address checks, and the lease should preserve an exit if the intended pharmacy use or build-out cannot be approved.
Local variation and address checks
For occupancy cost, no official statewide storefront-rent series was found that matched the canonical specification. A planning basket observed on August 29, 2026 used four current retail asking rents: Milwaukee $12.30/sq. ft./year, Madison $19.95, Green Bay $13.00 and Eau Claire $16.00. The simple median is $14.50/sq. ft./year. At 2,000 sq. ft., that is about $2,417 monthly base rent; the model adds a $983 monthly CAM/NNN/occupancy allowance, producing the $3,400 Base occupancy line. Asking rents are not executed leases and may differ in inclusions, condition and tenant-improvement economics.
A final address should be checked for permitted use, occupancy, building alterations, accessibility, fire/life safety, signage, parking/loading, waste handling, security, utilities and special-district requirements. Exact fees and processing times are Varies by city/county until confirmed by the issuing authority.
Market and sensitivity
Wisconsin demand is deep; margin quality still decides survival
A reliable Wisconsin pharmacy-market dollar amount is not publicly determinable from available category data without mixing chains, independents, front-end retail and prescription reimbursement, so no TAM is manufactured. As demand proxies, Census estimates about 5.97 million residents in 2025 and 20.8% age 65 or older. See Census QuickFacts for Wisconsin.
Demand does not ensure economics: payer and PBM contracts shape reimbursement. Wisconsin OCI regulates PBMs under 2021 Wisconsin Act 9, including contract, transparency and audit provisions, but that does not guarantee profitable reimbursement. Review the Wisconsin OCI PBM page.
A 10% Base volume shock at the same mix removes about $5,660 of monthly contribution, reducing passive profit to roughly $11,600. An extra $2,000 of fixed occupancy or labor cost lowers profit dollar for dollar. The Downside case combines lower volume with weaker prescription margin and produces a negative $5,360 monthly passive result even though the working owner still has positive cash benefit from supplying pharmacist labor.
Evidence register
Sources, method, and what still needs a quote
Research was reviewed August 29, 2026. Figures use 2026 USD unless a source period is stated. Official fees/rules are direct; wage and population data retain their periods; NCPA is national context. Modeled figures use the fixed configuration fingerprint and reconcile across startup, P&L, break-even and payback.
| Source / publisher | Geography / period | Evidence type | How used |
|---|---|---|---|
| Wisconsin DSPS – In-State Pharmacy | Wisconsin; current | Official fee/rule | Pharmacy credential, self-inspection and managing-pharmacist workflow. |
| Wisconsin DFI + Wisconsin DOR | Wisconsin; current | Official fee/rule | LLC annual report, BTR fee and state tax-account setup. |
| Wisconsin DWD | Wisconsin; 2026 rules/rates | Official rule | Workers' compensation trigger and unemployment-insurance treatment. |
| U.S. Bureau of Labor Statistics | Wisconsin; May 2025 | Reported government data | Pharmacist and pharmacy-technician wage basis; employer burden modeled separately. |
| NCPA 2025 Digest | U.S.; 2024 operations | Published benchmark | Independent-pharmacy prescription volume, sales mix and 18.2% gross-margin context. |
| NCPA startup benchmark | U.S.; older startup cohort | Published benchmark | Inventory-turn, receivable/payable and ramp context only; not copied as current Wisconsin dollars. |
| U.S. Census Bureau | Wisconsin; 2025 estimate | Reported government data | Population and age-65-plus demand proxies; not labeled market revenue. |
| DEA + CMS + FDA | Federal; current through 2026 | Official fee/rule | Controlled-substance registration, NPI workflow and DSCSA exemption context. |
| Wisconsin OCI | Wisconsin; current | Official rule/context | State PBM oversight context; not used to assume reimbursement levels. |
| Crexi multi-market retail listings | Four Wisconsin markets; Aug. 29, 2026 | Observed market quotes | Four asking-rent observations; median $14.50/sq. ft./year. Asking, not executed, rents. |
Evidence confidence is high for current state filing fees and credential requirements because they come from issuing authorities; moderate for wage and national operating benchmarks because their geography or period differs from the 2026 statewide model; and low/model-dependent for rent, build-out, insurance, software, payer economics, opening inventory and launch timing until actual quotes/contracts exist. The largest uncertainty is prescription contribution margin by payer and drug mix.
Before committing capital, confirm the address, current DSPS/DEA requirements, insurance, wholesaler/software quotes and written payer economics. This is a first-pass planning model – not legal, tax, reimbursement or investment advice – and should be rebuilt for the actual prescription mix, site and financing package.